Fluid delivery methods
US-2024408593-A1 · Dec 12, 2024 · US
US11111528B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11111528-B2 |
| Application number | US-201715412025-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 22, 2017 |
| Priority date | Nov 23, 2015 |
| Publication date | Sep 7, 2021 |
| Grant date | Sep 7, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides an apparatus and a method for detecting the presence of and/or determining the amount of a label-free microRNA using an atomic force microscope. The method is extremely selective and/or ultrasensitive. In particular, the present invention provides a cantilever comprising a probe that selectively binds to a double strand of DNA/RNA hybrid complex. The probe comprises a hybrid binding domain (HBD) or a variant thereof.
Opening claim text (preview).
What is claimed is: 1. An atomic force microscope comprising a cantilever, wherein said cantilever comprises a probing tip and a probe that is immobilized on said probing tip, wherein said probe comprises a hybrid binding domain (HBD) or a variant thereof, wherein said variant of HBD is elected from the group consisting of: an HBD linked to a glutathione S-transferase (GST); an HDB linked to a histidine-tag; and a biotinylated HBD, and wherein said HBD is capable of binding to a minor groove of a DNA/RNA hybrid duplex. 2. The atomic force microscope of claim 1 , wherein said HBD comprises an amino terminal (N-terminal) domain of a human ribonuclease 1 (RNase I). 3. The atomic force microscope of claim 1 , wherein said HBD comprises an amino acid sequence of SEQ ID NO: 1. 4. The atomic force microscope of claim 1 , wherein said probe comprises the variant of the HBD. 5. The atomic force microscope of claim 4 , wherein in said variant of the HBD is said HBD linked to said GST, wherein said GST is immobilized on said probing tip and is attached to the N-terminal of said HBD. 6. The atomic force microscope of claim 1 , wherein said probe is capable of complementarily binding to a target microRNA (miRNA). 7. The atomic force microscope of claim 1 , wherein said probe is capable of binding to a 2′—OH group of two consecutive bases of an RNA strand; three phosphodeoxyribose units of a DNA strand, or a combination thereof. 8. A method for detecting the presence of a target microRNA in a sample without labeling or amplifying, said method comprising: (a) contacting a substrate comprising a probe DNA that is immobilized on the surface of said substrate with a sample under conditions sufficient to form a DNA/RNA hybrid complex when a target microRNA (miRNA) is present in the sample and (b) detecting a presence of said DNA/RNA hybrid complex using the atomic force microscope of claim 1 . 9. The method of claim 8 , wherein said probe DNA comprises a nucleotide sequence that is complementary to said target miRNA. 10. The method of claim 8 further comprising the step of determining the amount of said target miRNA in said sample. 11. The method of claim 10 , wherein said step of determining the amount of said target miRNA in said sample comprises: determining the number of said DNA/RNA hybrid complexes detected per spot area of said substrate and calculating a total number of said target miRNA in said sample using Equation 1: T miRNA =( N ×( S/U ))/( E/ 100) (Eq. 1), wherein T miRNA =total number of said target miRNA; N=the number of said target miRNA per unit area of spot; S=total spot area within said substrate; U=unit area of spot; and E=% capture efficiency of miRNA by said probe. 12. The method of claim 8 , wherein said step of detecting the presence of said DNA/RNA hybrid complex comprises (i) determining a site where the adhesion force is observed at four consecutive pixels of 8 nm pixel size or (ii) determining three consecutive pixels where an adhesion force is observed at three consecutive pixels of 10 nm pixel size. 13. The method of claim 8 , wherein the sample is a fluid sample, and wherein the concentration of the target miRNA in the sample is 5×10 −20 to 2×10 −13 M. 14. The method of claim 8 , wherein a size of a probe DNA spot is calculated by an equation selected from the group consisting of: S D (μm)=([ M ]×10 19 /5) 0.5 (Eq. 2) and S D (μm)=([unit]/10) 0.5 (Eq. 3), wherein S D is Probe DNA spot diameter; [M] is miRNA concentration; and [unit] is miRNA number. 15. The method of claim 8 , wherein the substrate is selected from the group consisting of glass, metal, plastic, silicon, silicate, ceramic, a semiconductor, synthetic organic metal, a synthetic semiconductor, an alloy, and a combination thereof. 16. The method of claim 8 , wherein a site of the HBD binding to the DNA/RNA hybrid complex comprises: Y3, K33, and K34 of the HBD bound with the DNA strand of the DNA/RNA hybrid complex; W17 and F32 of the HBD bound with the RNA strand of the DNA/RNA hybrid complex; and a combination thereof. 17. The method of claim 8 , wherein said sample is obtained from a single cell.
using probe arrays or probe chips (C12Q1/6874 takes precedence) · CPC title
characterised by the detection means (C12Q1/6804 takes precedence) · CPC title
Probes, their manufacture, or their related instrumentation, e.g. holders · CPC title
Functionalisation · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.